Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
CAVIN3 deficiency promotes vascular normalization in ocular neovascular disease via ERK/JAG1 signaling pathway
Weiqi Li, Yeran Zhang, Hongjing Zhu, Na Su, Ruxu Sun, Xiying Mao, Qin Yang, Songtao Yuan
Weiqi Li, Yeran Zhang, Hongjing Zhu, Na Su, Ruxu Sun, Xiying Mao, Qin Yang, Songtao Yuan
View: Text | PDF
Research Article Angiogenesis Ophthalmology

CAVIN3 deficiency promotes vascular normalization in ocular neovascular disease via ERK/JAG1 signaling pathway

  • Text
  • PDF
Abstract

Multiple members of the caveolae-associated protein (Cavin) family are implicated in angiogenesis. However, the specific role of CAVIN3 in pathological angiogenesis within the eye remains unclear. The present study demonstrated that CAVIN3 knockdown in endothelial cells (ECs) promoted vascular normalization in ocular pathological neovascularization. Elevated CAVIN3 expression was observed in the ECs of retinal pigment epithelium/choroid complexes from patients with neovascular age-related macular degeneration and fibrovascular membranes from patients with proliferative diabetic retinopathy. Additionally, upregulated Cavin3 expression was detected in laser-induced choroidal neovascularization (CNV) and oxygen-induced retinopathy (OIR) mouse models. In both OIR and CNV mice, Cavin3 knockdown inhibited pathological neovascularization. Cavin3 deficiency further disrupted EC proliferation and vascular sprouting, thereby promoting vascular normalization by partially restoring microenvironmental hypoxia and reestablishing pericyte-EC interactions. Mechanistically, we demonstrated that zinc finger E-box–binding homeobox 1 (ZEB1) regulated CAVIN3 transcription in ECs under hypoxic conditions. CAVIN3 deficiency modulated pathological vascularization by inhibiting ERK phosphorylation, which downregulated jagged 1 (JAG1) expression. Conclusively, this study elucidated the protective role of endothelial CAVIN3 deficiency in pathological neovascularization models, addressing a gap in understanding the regulatory role of Cavins in angiogenesis. These findings suggested a therapeutic direction for ocular neovascular diseases.

Authors

Weiqi Li, Yeran Zhang, Hongjing Zhu, Na Su, Ruxu Sun, Xiying Mao, Qin Yang, Songtao Yuan

×

Figure 2

Cavin3 is upregulated in ocular neovascularization models.

Options: View larger image (or click on image) Download as PowerPoint
Cavin3 is upregulated in ocular neovascularization models.
(A) Experimen...
(A) Experimental scheme of OIR. (B) Differential Cavin3 expression in retinas of Control_P14 (n = 7), Control_P17 (n = 6), OIR_P14 (n = 6), and OIR_P17 (n = 8) mice (GSE234447). (C) UMAP visualization of scRNA-seq data (GSE150703). (D) A ridge plot shows Cavin3 expression in ECs. (E) Cavin3 mRNA in control and OIR retinas on P13, P17, P21, and P25. n = 3 per group. (F) Cavin3 protein in control and P17 OIR retinas, with α-tubulin as an internal reference. n = 3 per group. (G) Immunofluorescent staining of IB4 and Cavin3 in retinal flat mounts of control and P17 OIR mice. n = 6 per group. Scale bar: 50 μm. (H) Immunofluorescent staining of Cd31 and Cavin3 in retinal cryosections of control and OIR mice. n = 6 per group. Scale bars: 50 μm (white) and 10 μm (yellow). (I) Experimental scheme of CNV. (J) Cavin3 expression in control and CNV_D7 mice from bulk RNA-seq data (GSE207171). n = 3 per group. (K) mRNA levels of Cavin3 in the RPE-choroid-sclera complex of control, CNV_D7, and CNV_D14 mice. n = 3 per group. (L) Immunoblotting of Cavin3 in the RPE-choroid-sclera complex of control and CNV_D7, using α-tubulin as an internal reference. n = 3 per group. (M) Immunofluorescent costaining of Cd31 and Cavin3 in frozen sections of eyes from control, CNV_D7, and CNV_D14 mice. n = 6 per group. Scale bars: 50 μm (white) and 10 μm (yellow). (N) Experimental protocols for hypoxic treatment. (O and P) mRNA (O) and protein (P) levels of CAVIN3 in HRMECs after control or hypoxic treatment. β-Actin was used as an internal reference. n = 3 per group. Data are presented as mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 by 1-way ANOVA with Tukey’s multiple-comparison test (B and K) or 2-tailed Student’s t test (E–H, J, L, M, O, and P).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts